-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Sutro Biopharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2023.
- Sutro Biopharma, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$48.7M, a 5.43% decline year-over-year.
- Sutro Biopharma, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$106M, a 33.2% increase year-over-year.
- Sutro Biopharma, Inc. annual Operating Income (Loss) for 2023 was -$89.3M, a 30.8% increase from 2022.
- Sutro Biopharma, Inc. annual Operating Income (Loss) for 2022 was -$129M, a 30.9% decline from 2021.
- Sutro Biopharma, Inc. annual Operating Income (Loss) for 2021 was -$98.5M, a 38.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)